New 52 Week High Today

Blueprint Medicines Corp BPMC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
107.19UNCH (UNCH)
Volume
34,122
Close
107.19quote price arrow up+0.19 (+0.18%)
Volume
969,857
52 week range
43.89 - 110.93
Loading...
  • Open109.82
  • Day High110.93
  • Day Low106.07
  • Prev Close107.00
  • 52 Week High110.93
  • 52 Week High Date05/03/24
  • 52 Week Low43.89
  • 52 Week Low Date10/25/23

Key Stats

  • Market Cap6.733B
  • Shares Out62.81M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change16.21

KEY STATS

  • Open109.82
  • Day High110.93
  • Day Low106.07
  • Prev Close107.00
  • 52 Week High110.93
  • 52 Week High Date05/03/24
  • 52 Week Low43.89
  • 52 Week Low Date10/25/23
  • Market Cap6.733B
  • Shares Out62.81M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta0.67
  • YTD % Change16.21

RATIOS/PROFITABILITY

  • EPS (TTM)-4.82
  • P/E (TTM)-22.23
  • Fwd P/E (NTM)-19.45
  • EBITDA (TTM)-474.612M
  • ROE (TTM)-157.13%
  • Revenue (TTM)249.38M
  • Gross Margin (TTM)96.58%
  • Net Margin (TTM)-203.30%
  • Debt To Equity (MRQ)182.85%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Blueprint Medicines Corp

 

Profile

MORE
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and...
Jeffrey Albers J.D.
Chairman of the Board
Kathryn Haviland
President, Chief Executive Officer, Director
Christina Rossi
Chief Operating Officer
Michael Landsittel
Chief Financial Officer
Christopher Murray Ph.D.
Executive Vice President, Chief Technical Operations and Quality Officer
Address
45 Sidney Street
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
IONS
Ionis Pharmaceuticals Inc
41.97-1.12-2.60%
CORT
Corcept Therapeutics Inc
24.52-0.54-2.15%
PBH
Prestige Consumer Healthcare Inc
70.00-1.26-1.77%
AMPH
Amphastar Pharmaceuticals Inc
42.46-0.20-0.47%
INVA
Innoviva Inc
15.20-0.17-1.11%